• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过人工智能提取的组织纤维框架分析改进肝切除术后肝癌预后模型

Improving HCC Prognostic Models after Liver Resection by AI-Extracted Tissue Fiber Framework Analytics.

作者信息

Stulpinas Rokas, Morkunas Mindaugas, Rasmusson Allan, Drachneris Julius, Augulis Renaldas, Gulla Aiste, Strupas Kestutis, Laurinavicius Arvydas

机构信息

Faculty of Medicine, Institute of Biomedical Sciences, Department of Pathology and Forensic Medicine, Vilnius University, 03101 Vilnius, Lithuania.

National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, 08406 Vilnius, Lithuania.

出版信息

Cancers (Basel). 2023 Dec 24;16(1):106. doi: 10.3390/cancers16010106.

DOI:10.3390/cancers16010106
PMID:38201532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10778366/
Abstract

Despite advances in diagnostic and treatment technologies, predicting outcomes of patients with hepatocellular carcinoma (HCC) remains a challenge. Prognostic models are further obscured by the variable impact of the tumor properties and the remaining liver parenchyma, often affected by cirrhosis or non-alcoholic fatty liver disease that tend to precede HCC. This study investigated the prognostic value of reticulin and collagen microarchitecture in liver resection samples. We analyzed 105 scanned tissue sections that were stained using a Gordon and Sweet's silver impregnation protocol combined with Picric Acid-Sirius Red. A convolutional neural network was utilized to segment the red-staining collagen and black linear reticulin strands, generating a detailed map of the fiber structure within the HCC and adjacent liver tissue. Subsequent hexagonal grid subsampling coupled with automated epithelial edge detection and computational fiber morphometry provided the foundation for region-specific tissue analysis. Two penalized Cox regression models using LASSO achieved a concordance index (C-index) greater than 0.7. These models incorporated variables such as patient age, tumor multifocality, and fiber-derived features from the epithelial edge in both the tumor and liver compartments. The prognostic value at the tumor edge was derived from the reticulin structure, while collagen characteristics were significant at the epithelial edge of peritumoral liver. The prognostic performance of these models was superior to models solely reliant on conventional clinicopathologic parameters, highlighting the utility of AI-extracted microarchitectural features for the management of HCC.

摘要

尽管诊断和治疗技术取得了进展,但预测肝细胞癌(HCC)患者的预后仍然是一项挑战。肿瘤特性和剩余肝实质的可变影响进一步模糊了预后模型,这些肝实质通常受肝硬化或非酒精性脂肪性肝病影响,而这些疾病往往先于HCC出现。本研究调查了肝切除样本中网硬蛋白和胶原微结构的预后价值。我们分析了105个扫描组织切片,这些切片采用戈登-斯威特银浸染法结合苦味酸-天狼星红染色。利用卷积神经网络对红色染色的胶原和黑色线性网硬蛋白链进行分割,生成HCC及相邻肝组织内纤维结构的详细图谱。随后的六边形网格二次抽样,结合自动上皮边缘检测和计算纤维形态学,为区域特异性组织分析奠定了基础。使用LASSO的两个惩罚Cox回归模型的一致性指数(C指数)大于0.7。这些模型纳入了患者年龄、肿瘤多灶性以及肿瘤和肝区上皮边缘的纤维衍生特征等变量。肿瘤边缘的预后价值源于网硬蛋白结构,而胶原特征在肿瘤周围肝组织的上皮边缘具有显著性。这些模型的预后性能优于仅依赖传统临床病理参数的模型,突出了人工智能提取的微结构特征在HCC管理中的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/f1dd64ac907f/cancers-16-00106-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/7a845e5d9cb8/cancers-16-00106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/5b03812993e1/cancers-16-00106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/4044737727e5/cancers-16-00106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/08a2b4336dd0/cancers-16-00106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/f1dd64ac907f/cancers-16-00106-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/7a845e5d9cb8/cancers-16-00106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/5b03812993e1/cancers-16-00106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/4044737727e5/cancers-16-00106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/08a2b4336dd0/cancers-16-00106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c58/10778366/f1dd64ac907f/cancers-16-00106-g005.jpg

相似文献

1
Improving HCC Prognostic Models after Liver Resection by AI-Extracted Tissue Fiber Framework Analytics.通过人工智能提取的组织纤维框架分析改进肝切除术后肝癌预后模型
Cancers (Basel). 2023 Dec 24;16(1):106. doi: 10.3390/cancers16010106.
2
Artificial intelligence-based reticulin proportionate area - a novel histological outcome predictor in hepatocellular carcinoma.基于人工智能的网状纤维比例面积——肝细胞癌的一种新的组织学预后预测因子。
Histopathology. 2023 Oct;83(4):512-525. doi: 10.1111/his.15001. Epub 2023 Jun 30.
3
Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review.人工智能在肝细胞癌患者中的预后作用:一项系统综述。
World J Gastroenterol. 2020 Nov 14;26(42):6679-6688. doi: 10.3748/wjg.v26.i42.6679.
4
Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples.通过肝切除样本的界面密度分布图评估CD8 +淋巴细胞在肝细胞癌及癌旁实质中的预后价值
Cancers (Basel). 2023 Jan 5;15(2):366. doi: 10.3390/cancers15020366.
5
Automated fibrosis phenotyping of liver tissue from non-tumor lesions of patients with and without hepatocellular carcinoma after liver transplantation for non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者肝移植后非肿瘤性病变肝组织的纤维化表型自动化分析:有无肝细胞癌患者之间的比较。
Hepatol Int. 2022 Jun;16(3):555-561. doi: 10.1007/s12072-022-10340-9. Epub 2022 May 13.
6
Stiffness on shear wave elastography as a potential microenvironment biomarker for predicting tumor recurrence in HBV-related hepatocellular carcinoma.剪切波弹性成像中的硬度作为预测乙肝相关肝细胞癌肿瘤复发的潜在微环境生物标志物。
Insights Imaging. 2023 Sep 12;14(1):147. doi: 10.1186/s13244-023-01505-7.
7
DLNLF-net: Denoised local and non-local deep features fusion network for malignancy characterization of hepatocellular carcinoma.DLNLF-net:用于肝细胞癌恶性特征分析的去噪局部和非局部深度特征融合网络。
Comput Methods Programs Biomed. 2022 Dec;227:107201. doi: 10.1016/j.cmpb.2022.107201. Epub 2022 Oct 25.
8
High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.高迁移率族蛋白盒1表达与肝细胞癌合并肝硬化患者的瘤周巨噬细胞浸润及不良预后相关。
BMC Cancer. 2016 Nov 11;16(1):880. doi: 10.1186/s12885-016-2883-z.
9
Biopsies of hepatocellular carcinoma with no reticulin loss: an important diagnostic pitfall.无网状纤维丢失的肝细胞癌活检:一个重要的诊断陷阱。
Hum Pathol. 2021 Jan;107:20-28. doi: 10.1016/j.humpath.2020.09.015. Epub 2020 Oct 8.
10
Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH.借助人工智能分析的数字病理学能更深入地洞察非酒精性脂肪性肝炎(NASH)中治疗引起的纤维化消退情况。
J Hepatol. 2022 Nov;77(5):1399-1409. doi: 10.1016/j.jhep.2022.06.018. Epub 2022 Jun 30.

本文引用的文献

1
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys.探索二级医疗途径中对非侵入性肝纤维化检测态度的变化:两项全国性调查的比较
Frontline Gastroenterol. 2023 Jun 15;14(6):483-490. doi: 10.1136/flgastro-2023-102415. eCollection 2023.
2
Augmented liver pathology: artificial intelligence and the assessment of hepatocellular neoplasms.增强型肝脏病理学:人工智能与肝细胞肿瘤评估
Histopathology. 2023 Oct;83(4):509-511. doi: 10.1111/his.15020.
3
Artificial intelligence-based reticulin proportionate area - a novel histological outcome predictor in hepatocellular carcinoma.
基于人工智能的网状纤维比例面积——肝细胞癌的一种新的组织学预后预测因子。
Histopathology. 2023 Oct;83(4):512-525. doi: 10.1111/his.15001. Epub 2023 Jun 30.
4
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.非酒精性脂肪性肝病患者临床结局预测的无创性检查和组织学检查的效能:一项个体参与者数据荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Aug;8(8):704-713. doi: 10.1016/S2468-1253(23)00141-3. Epub 2023 Jun 5.
5
Artificial Intelligence-Based Opportunities in Liver Pathology-A Systematic Review.基于人工智能的肝脏病理学机遇——一项系统综述
Diagnostics (Basel). 2023 May 19;13(10):1799. doi: 10.3390/diagnostics13101799.
6
Prognostic Scores and Survival Rates by Etiology of Hepatocellular Carcinoma: A Review.肝细胞癌病因的预后评分与生存率:综述
J Clin Med Res. 2023 Apr;15(4):200-207. doi: 10.14740/jocmr4902. Epub 2023 Apr 28.
7
The Global Burden of Liver Disease.《全球肝脏疾病负担》
Clin Gastroenterol Hepatol. 2023 Jul;21(8):1978-1991. doi: 10.1016/j.cgh.2023.04.015. Epub 2023 Apr 28.
8
Global Epidemiology and Genetics of Hepatocellular Carcinoma.全球肝细胞癌的流行病学和遗传学
Gastroenterology. 2023 Apr;164(5):766-782. doi: 10.1053/j.gastro.2023.01.033. Epub 2023 Feb 2.
9
Survey of liver pathologists to assess attitudes towards digital pathology and artificial intelligence.肝脏病理学家调查,评估对数字病理学和人工智能的态度。
J Clin Pathol. 2023 Dec 14;77(1):27-33. doi: 10.1136/jcp-2022-208614.
10
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.